These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 28556967)
1. Teriparatide Treatment Improves Bone Defect Healing Via Anabolic Effects on New Bone Formation and Non-Anabolic Effects on Inhibition of Mast Cells in a Murine Cranial Window Model. Zhang L; Wang T; Chang M; Kaiser C; Kim JD; Wu T; Cao X; Zhang X; Schwarz EM J Bone Miner Res; 2017 Sep; 32(9):1870-1883. PubMed ID: 28556967 [TBL] [Abstract][Full Text] [Related]
2. PTH-enhanced structural allograft healing is associated with decreased angiopoietin-2-mediated arteriogenesis, mast cell accumulation, and fibrosis. Dhillon RS; Xie C; Tyler W; Calvi LM; Awad HA; Zuscik MJ; O'Keefe RJ; Schwarz EM J Bone Miner Res; 2013 Mar; 28(3):586-97. PubMed ID: 22991274 [TBL] [Abstract][Full Text] [Related]
3. Controlling Arteriogenesis and Mast Cells Are Central to Bioengineering Solutions for Critical Bone Defect Repair Using Allografts. Antebi B; Zhang L; Sheyn D; Pelled G; Zhang X; Gazit Z; Schwarz EM; Gazit D Bioengineering (Basel); 2016 Mar; 3(1):. PubMed ID: 27141513 [TBL] [Abstract][Full Text] [Related]
4. Teriparatide (recombinant parathyroid hormone 1-34) enhances bone allograft integration in a clinically relevant pig model of segmental mandibulectomy. Pelled G; Lieber R; Avalos P; Cohn-Schwartz D; Tawackoli W; Roth J; Knapp E; Schwarz EM; Awad HA; Gazit D; Gazit Z J Tissue Eng Regen Med; 2020 Aug; 14(8):1037-1049. PubMed ID: 32483878 [TBL] [Abstract][Full Text] [Related]
5. Teriparatide attenuates scarring around murine cranial bone allograft via modulation of angiogenesis. Cohn Yakubovich D; Eliav U; Yalon E; Schary Y; Sheyn D; Cook-Wiens G; Sun S; McKenna CE; Lev S; Binshtok AM; Pelled G; Navon G; Gazit D; Gazit Z Bone; 2017 Apr; 97():192-200. PubMed ID: 28119180 [TBL] [Abstract][Full Text] [Related]
6. Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone. Pettway GJ; Schneider A; Koh AJ; Widjaja E; Morris MD; Meganck JA; Goldstein SA; McCauley LK Bone; 2005 Jun; 36(6):959-70. PubMed ID: 15878317 [TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal Analyses of Osteogenesis and Angiogenesis via Intravital Imaging in Cranial Bone Defect Repair. Huang C; Ness VP; Yang X; Chen H; Luo J; Brown EB; Zhang X J Bone Miner Res; 2015 Jul; 30(7):1217-30. PubMed ID: 25640220 [TBL] [Abstract][Full Text] [Related]
8. Combination therapy with PTH and DBM cannot heal a critical sized murine femoral defect. Pensak M; Hong SH; Dukas A; Bayron J; Tinsley B; Jain A; Tang A; Rowe D; Lieberman JR J Orthop Res; 2015 Aug; 33(8):1242-9. PubMed ID: 25877402 [TBL] [Abstract][Full Text] [Related]
9. Teriparatide promotes healing of critical size femur defect through accelerating angiogenesis and degradation of β-TCP in OVX osteoporotic rat model. Xie Z; Weng S; Li H; Yu X; Lu S; Huang K; Wu Z; Bai B; Boodhun V; Yang L Biomed Pharmacother; 2017 Dec; 96():960-967. PubMed ID: 29198925 [TBL] [Abstract][Full Text] [Related]
11. Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model. Reynolds DG; Takahata M; Lerner AL; O'Keefe RJ; Schwarz EM; Awad HA Bone; 2011 Mar; 48(3):562-70. PubMed ID: 20950720 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of teriparatide effect on healing of autografted mandibular defects in rats. Zandi M; Dehghan A; Gheysari F; Rezaeian L; Mohammad Gholi Mezerji N J Craniomaxillofac Surg; 2019 Jan; 47(1):120-126. PubMed ID: 30528562 [TBL] [Abstract][Full Text] [Related]
13. Defective bone repair in mast cell-deficient Cpa3Cre/+ mice. Ramirez-GarciaLuna JL; Chan D; Samberg R; Abou-Rjeili M; Wong TH; Li A; Feyerabend TB; Rodewald HR; Henderson JE; Martineau PA PLoS One; 2017; 12(3):e0174396. PubMed ID: 28350850 [TBL] [Abstract][Full Text] [Related]
14. Effect of Intermittent Administration of Teriparatide (Parathyroid Hormone 1-34) on Bone Morphogenetic Protein-Induced Bone Formation in a Rat Model of Spinal Fusion. Morimoto T; Kaito T; Kashii M; Matsuo Y; Sugiura T; Iwasaki M; Yoshikawa H J Bone Joint Surg Am; 2014 Jul; 96(13):e107. PubMed ID: 24990981 [TBL] [Abstract][Full Text] [Related]
15. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1. Bodine PV; Seestaller-Wehr L; Kharode YP; Bex FJ; Komm BS J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082 [TBL] [Abstract][Full Text] [Related]
16. Delayed short-course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction. Takahata M; Schwarz EM; Chen T; O'Keefe RJ; Awad HA J Bone Miner Res; 2012 Jan; 27(1):26-37. PubMed ID: 21956542 [TBL] [Abstract][Full Text] [Related]
17. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. Brixen KT; Christensen PM; Ejersted C; Langdahl BL Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497 [TBL] [Abstract][Full Text] [Related]
18. [Anabolic action of teriparatide to osteoporotic patients]. Hasegawa T; Miyamoto Y; Yamamoto T; Amizuka N Nihon Yakurigaku Zasshi; 2019; 153(1):16-21. PubMed ID: 30643087 [TBL] [Abstract][Full Text] [Related]
19. Effects of combined menaquinone-4 and PTH Weng SJ; Xie ZJ; Wu ZY; Yan DY; Tang JH; Shen ZJ; Li H; Bai BL; Boodhun V; Eric Dong XD; Yang L Endocrine; 2019 Feb; 63(2):376-384. PubMed ID: 30244350 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). Alkhiary YM; Gerstenfeld LC; Krall E; Westmore M; Sato M; Mitlak BH; Einhorn TA J Bone Joint Surg Am; 2005 Apr; 87(4):731-41. PubMed ID: 15805200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]